PROSPECTIVE EVALUATION OF THYMOSIN FRACTION-V IMMUNOTHERAPY IN PATIENTS WITH NON-SMALL CELL LUNG-CANCER RECEIVING VINDESINE, DOXORUBICIN, AND CISPLATIN (VAP) CHEMOTHERAPY

被引：4

作者：

BEDIKIAN, AY

PATT, YZ

MURPHY, WK

UMSAWASADI, T

CARR, DT

HERSH, EM

BODEY, GP

VALDIVIESO, M

机构：

[1] UNIV TEXAS,MD ANDERSON HOSP & TUMOR INST,DEPT INTERNAL MED,HOUSTON,TX 77030

[2] UNIV TEXAS,MD ANDERSON HOSP & TUMOR INST,DEPT DEV THERAPEUT,HOUSTON,TX 77030

来源：

AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS | 1984年 / 7卷 / 05期

关键词：

D O I：

10.1097/00000421-198410000-00002

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：399 / 404

页数：6

共 25 条

[1] METASTATIC NON-OAT-CELL BRONCHOGENIC CARCINOMA - THERAPY WITH CYCLOPHOSPHAMIDE, DOXORUBICIN, METHOTREXATE, AND PROCARBAZINE (CAMP) [J].

BITRAN, JD ;

DESSER, RK ;

DEMEESTER, T ;

GOLOMB, HM .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1978, 240 (25) :2743-2746

[2]

CASPER ES, 1979, CANCER TREAT REP, V63, P2107

[3]

CASPER ES, 1979, P AM ASSOC CANC RES, V20, P337

[4] CHEMOTHERAPHY FOR BRONCHOGENIC CARCINOMA - METHOTREXATE, DOXORUBICIN, CYCLOPHOSPHAMIDE, AND LOMUSTINE [J].

CHAHINIAN, AP ;

ARNOLD, DJ ;

COHEN, JM ;

PURPORA, DP ;

JAFFREY, IS ;

TEIRSTEIN, AS ;

KIRSCHNER, PA ;

HOLLAND, JF .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1977, 237 (22) :2392-2396

[5]

CORTES EP, 1974, CANCER, V34, P518, DOI 10.1002/1097-0142(197409)34:3<518::AID-CNCR2820340307>3.0.CO

[6]

2-P

[7]

EAGAN RT, 1979, CANCER TREAT REP, V63, P1589

[8]

EAGAN RT, 1977, CANCER TREAT REP, V61, P1339

[9]

GEHAN EA, 1965, BIOMETRIKA, V52, P203, DOI 10.1093/biomet/52.1-2.203

[10]

GRALLA RJ, 1979, CANCER TREAT REP, V63, P1343

← 1 2 3 →